AprilBio Advisor Seo Sang-jun Exercises Stock Options to Acquire 20,000 Shares, Minimal Dilution Impact

Seo Sang-jun, a non-registered executive and advisor of AprilBio, exercised stock options on April 13, 2026 to acquire 20,000 common shares at 3,020 KRW per share.
This acquisition increases his ownership from 0% to 0.09%, with a dilution ratio of only 0.09% relative to total outstanding shares, resulting in minimal impact on existing shareholder value.
The transaction represents an insider's personal equity investment and is not a capital-raising event for the company.
[AI Summary]The small-scale stock option exercise by an AprilBio insider results in negligible dilution of 0.09% with no adverse effect on shareholder value. This routine disclosure does not alter the company's capital structure or operational funding.